Buscar
Codexis Inc
CDXSAñadir a la lista de seguimiento
1.400USD
-0.080-5.41%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
150.59MCap. mercado
PérdidaP/E TTM
Más Datos de Codexis Inc Compañía
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Información de Codexis Inc
Símbolo de cotizaciónCDXS
Nombre de la empresaCodexis Inc
Fecha de salida a bolsaApr 22, 2010
Director ejecutivoMoore (Alison)
Número de empleados188
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 22
Dirección200 Penobscot Dr
CiudadREDWOOD CITY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94063
Teléfono16504218100
Sitio Webhttps://www.codexis.com/
Símbolo de cotizaciónCDXS
Fecha de salida a bolsaApr 22, 2010
Director ejecutivoMoore (Alison)
Ejecutivos de Codexis Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
--
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
--
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
84.81K
-3.07%
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
66.81K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Codexis Inc?
Los cinco principales accionistas de Codexis Inc son: Dr. Alison Moore, Ph.D.
¿Cuántas instituciones poseen acciones de Codexis Inc (CDXS)?
A fecha de 2026Q1, 273 instituciones poseen acciones de Codexis Inc, con un valor de mercado combinado de aproximadamente 66.34M, lo que representa el 73.00% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -13883230.00.